KCM
CNCE

Kynam Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Kynam Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,420,349
Closed -$25.8M – 39
2022
Q4 		$25.8M Buy
4,420,349
+2,747,308
+164% +$16M 3.96% 9
2022
Q3 		$11.2M Buy
1,673,041
+673,041
+67% +$4.51M 2.36% 13
2022
Q2 		$4.21M Buy
+1,000,000
New +$4.21M 1.08% 19